{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:55:24Z","timestamp":1784717724943,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Hubei Province","award":["2024AFB470"],"award-info":[{"award-number":["2024AFB470"]}]},{"name":"the Funding for Scientific Research Projects from Wuhan Municipal Health Commission","award":["WX23Q11"],"award-info":[{"award-number":["WX23Q11"]}]},{"name":"Municipal Natural Science Foundation Exploratory Program (Morning Light Program) Key Special Project for Clinical Research in Municipal Medical Institutions","award":["2025020701020262"],"award-info":[{"award-number":["2025020701020262"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48902-8","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:28:21Z","timestamp":1776241701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ADAM15 promotes the progression and metastasis of hepatocellular carcinoma by activating the JNK\/p38 pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Xu","family":"Junhui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Mengyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"1","key":"48902_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng, J. et al. Hepatocellular carcinoma: Signaling pathways and therapeutic advances. Signal. Transduct. Target. Ther. 10 (1), 35 (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"48902_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74 (1), 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"48902_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/14712598.2024.2363234","volume":"24","author":"F Rossari","year":"2024","unstructured":"Rossari, F. et al. Treatment options for advanced hepatocellular carcinoma: The potential of biologics. Expert Opin. Biol. Ther. 24 (6), 455\u2013470 (2024).","journal-title":"Expert Opin. Biol. Ther."},{"issue":"1","key":"48902_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cld.2024.08.010","volume":"29","author":"E Kinsey","year":"2025","unstructured":"Kinsey, E. & Morse, M. A. Systemic therapy for hepatocellular carcinoma. Clin. Liver Dis. 29 (1), 105\u2013124 (2025).","journal-title":"Clin. Liver Dis."},{"key":"48902_CR5","doi-asserted-by":"publisher","first-page":"e18761429310703","DOI":"10.2174\/0118761429310703240823045808","volume":"17","author":"B Sensi","year":"2024","unstructured":"Sensi, B. et al. Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation. Curr. Mol. Pharmacol. 17, e18761429310703 (2024).","journal-title":"Curr. Mol. Pharmacol."},{"issue":"1","key":"48902_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","volume":"13","author":"Y Yin","year":"2024","unstructured":"Yin, Y. et al. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: From bench to bedside. Exp. Hematol. Oncol. 13 (1), 72 (2024).","journal-title":"Exp. Hematol. Oncol."},{"key":"48902_CR7","doi-asserted-by":"publisher","first-page":"217191","DOI":"10.1016\/j.canlet.2024.217191","volume":"604","author":"H Han","year":"2024","unstructured":"Han, H. et al. RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma. Cancer Lett. 604, 217191 (2024).","journal-title":"Cancer Lett."},{"issue":"1","key":"48902_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1158\/0008-5472.CAN-24-2324","volume":"85","author":"YW Luo","year":"2025","unstructured":"Luo, Y. W. et al. HIF1\u03b1 counteracts TGF\u03b21-driven TSP1 expression in endothelial cells to stimulate angiogenesis in the hypoxic tumor microenvironment. Cancer Res. 85 (1), 69\u201383 (2025).","journal-title":"Cancer Res."},{"issue":"9","key":"48902_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","volume":"31","author":"W Ye","year":"2024","unstructured":"Ye, W. et al. Association between higher expression of Vav1 in hepatocellular carcinoma and unfavourable clinicopathological features and prognosis. Protein Pept. Lett. 31 (9), 706\u2013713 (2024).","journal-title":"Protein Pept. Lett."},{"key":"48902_CR10","first-page":"e18761429358008","volume":"17","author":"W Xu","year":"2024","unstructured":"Xu, W. et al. Upregulation of miR-3130-5p enhances hepatocellular carcinoma growth by suppressing ferredoxin 1: miR-3130-5p enhances HCC growth via inhibiting FDX1. Curr. Mol. Pharmacol. 17, e18761429358008 (2024).","journal-title":"Curr. Mol. Pharmacol."},{"key":"48902_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/CEJ.0000000000000939","volume":"34","author":"L Meng","year":"2024","unstructured":"Meng, L. et al. Genetic alterations are related to clinicopathological features and risk of recurrence\/metastasis of hepatocellular carcinoma. Eur. J. Cancer Prev. 34, 456 (2024).","journal-title":"Eur. J. Cancer Prev."},{"issue":"1","key":"48902_CR12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1186\/s12967-024-05998-8","volume":"22","author":"W Yuan","year":"2024","unstructured":"Yuan, W. et al. The role of MAPK pathway in gastric cancer: Unveiling molecular crosstalk and therapeutic prospects. J. Transl Med. 22 (1), 1142 (2024).","journal-title":"J. Transl Med."},{"issue":"1","key":"48902_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello, M. & Roux, P. P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 75 (1), 50\u201383 (2011).","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"2","key":"48902_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/jipb.13215","volume":"64","author":"M Zhang","year":"2022","unstructured":"Zhang, M. & Zhang, S. Mitogen-activated protein kinase cascades in plant signaling. J. Integr. Plant. Biol. 64 (2), 301\u2013341 (2022).","journal-title":"J. Integr. Plant. Biol."},{"issue":"4","key":"48902_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","volume":"37","author":"M Drosten","year":"2020","unstructured":"Drosten, M. & Barbacid, M. Targeting the MAPK pathway in KRAS-driven tumors. Cancer Cell. 37 (4), 543\u2013550 (2020).","journal-title":"Cancer Cell."},{"issue":"10","key":"48902_CR16","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.3390\/ijms23105702","volume":"23","author":"E Rovida","year":"2022","unstructured":"Rovida, E. & Tusa, I. Targeting MAPK in cancer 2.0. Int. J. Mol. Sci. 23 (10), 5702 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"2\u20133","key":"48902_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0014-5793(99)00119-2","volume":"445","author":"BL Tang","year":"1999","unstructured":"Tang, B. L. & Hong, W. ADAMTS: A novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. FEBS Lett. 445 (2\u20133), 223\u2013225 (1999).","journal-title":"FEBS Lett."},{"issue":"4","key":"48902_CR18","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1158\/1078-0432.CCR-08-1585","volume":"15","author":"MJ Duffy","year":"2009","unstructured":"Duffy, M. J. et al. Role of ADAMs in cancer formation and progression. Clin. Cancer Res. 15 (4), 1140\u20131144 (2009).","journal-title":"Clin. Cancer Res."},{"key":"48902_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000015549","volume":"88","author":"I K\u00e4rkk\u00e4inen","year":"2000","unstructured":"K\u00e4rkk\u00e4inen, I., Karhu, R. & Huovila, A. P. Assignment of the ADAM15 gene to human chromosome band 1q21.3 by in situ hybridization. Cytogenet. Cell. Genet. 88, 206\u2013207 (2000).","journal-title":"Cytogenet. Cell. Genet."},{"issue":"45","key":"48902_CR20","doi-asserted-by":"publisher","first-page":"34922","DOI":"10.1074\/jbc.M001953200","volume":"275","author":"K Eto","year":"2000","unstructured":"Eto, K. et al. RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction. J. Biol. Chem. 275 (45), 34922\u201334930 (2000).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"48902_CR21","doi-asserted-by":"publisher","first-page":"12540","DOI":"10.1038\/s41598-019-49021-3","volume":"9","author":"J Mattern","year":"2019","unstructured":"Mattern, J. et al. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells. Sci. Rep. 9 (1), 12540 (2019).","journal-title":"Sci. Rep."},{"issue":"16","key":"48902_CR22","doi-asserted-by":"publisher","first-page":"20395","DOI":"10.18632\/aging.203425","volume":"13","author":"JH Xu","year":"2021","unstructured":"Xu, J. H. et al. ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma. Aging (Albany NY). 13 (16), 20395\u201320417 (2021).","journal-title":"Aging (Albany NY)"},{"key":"48902_CR23","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98\u2013102 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"48902_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","volume":"23","author":"YT Chan","year":"2024","unstructured":"Chan, Y. T. et al. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol. Cancer. 23 (1), 189 (2024).","journal-title":"Mol. Cancer"},{"issue":"Suppl","key":"48902_CR25","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","volume":"31","author":"SY Hwang","year":"2025","unstructured":"Hwang, S. Y. et al. Hepatocellular carcinoma: Updates on epidemiology, surveillance, diagnosis and treatment. Clin. Mol. Hepatol. 31 (Suppl), S228\u2013S254 (2025).","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"48902_CR26","doi-asserted-by":"publisher","first-page":"217191","DOI":"10.1016\/j.canlet.2024.217191","volume":"604","author":"H Han","year":"2024","unstructured":"Han, H. et al. RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma. Cancer Lett. 604 (1), 217191 (2024).","journal-title":"Cancer Lett."},{"key":"48902_CR27","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1038\/s41388-025-03550-6","volume":"41","author":"H Han","year":"2025","unstructured":"Han, H. et al. RBM30 recruits DOT1L to activate STAT1 transcription and drive immune evasion in hepatocellular carcinoma. Oncogene 41, 3955\u20133973 (2025).","journal-title":"Oncogene"},{"issue":"40","key":"48902_CR28","doi-asserted-by":"publisher","first-page":"e09477","DOI":"10.1002\/advs.202509477","volume":"12","author":"H Han","year":"2024","unstructured":"Han, H. et al. ASH2L-K312-Lac stimulates angiogenesis in tumors to expedite the malignant progression of hepatocellular carcinoma. Adv. Sci. (Weinh) 12 (40), e09477 (2025).","journal-title":"Adv. Sci. (Weinh)"},{"key":"48902_CR29","doi-asserted-by":"publisher","first-page":"117714","DOI":"10.1016\/j.biopha.2024.117714","volume":"181","author":"J Yuan","year":"2024","unstructured":"Yuan, J. et al. Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers. Biomed. Pharmacother. 181, 117714 (2024).","journal-title":"Biomed. Pharmacother"},{"issue":"16","key":"48902_CR30","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.3390\/ijms25168972","volume":"25","author":"P Tomecka","year":"2024","unstructured":"Tomecka, P. et al. Factors determining epithelial-mesenchymal transition in cancer progression. Int. J. Mol. Sci. 25 (16), 8972 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"48902_CR31","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.3390\/ijms26094364","volume":"26","author":"S Ghafoor","year":"2025","unstructured":"Ghafoor, S. et al. Molecular mechanisms regulating epithelial mesenchymal transition (EMT) to promote cancer progression. Int. J. Mol. Sci. 26 (9), 4364 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"48902_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","volume":"20","author":"A Moyer","year":"2025","unstructured":"Moyer, A., Tanaka, K. & Cheng, E. H. Apoptosis in cancer biology and therapy. Annu. Rev. Pathol. 20 (1), 303\u2013328 (2025).","journal-title":"Annu. Rev. Pathol."},{"issue":"22","key":"48902_CR33","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3390\/cells13221838","volume":"13","author":"M Mustafa","year":"2024","unstructured":"Mustafa, M. et al. Apoptosis: A comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications. Cells. 13 (22), 1838 (2024).","journal-title":"Cells"},{"issue":"3","key":"48902_CR34","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/ijms21031102","volume":"21","author":"S Lee","year":"2020","unstructured":"Lee, S., Rauch, J. & Kolch, W. Targeting MAPK signaling in cancer: Mechanisms of drug resistance and sensitivity. Int. J. Mol. Sci. 21 (3), 1102 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"48902_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-230X-3-19","volume":"3","author":"H Huynh","year":"2003","unstructured":"Huynh, H. et al. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosis. BMC Gastroenterol. 3, 19 (2003).","journal-title":"BMC Gastroenterol."},{"issue":"12","key":"48902_CR36","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.3390\/cancers13123026","volume":"13","author":"H Moon","year":"2021","unstructured":"Moon, H. & Ro, S. W. MAPK\/ERK signaling pathway in hepatocellular carcinoma. Cancers (Basel). 13 (12), 3026 (2021).","journal-title":"Cancers (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48902-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48902-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48902-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:21:20Z","timestamp":1780618880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48902-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48902"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48902-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17507"}}